Pictet Asset Management (UK)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-60,475
| Closed | -$5.56M | – | 920 |
|
|
2015
Q1 | $5.56M | Sell |
60,475
-36,018
| -37% | -$3.31M | 0.02% | 566 |
|
|
2014
Q4 | $8.95M | Buy |
96,493
+56,093
| +139% | +$5.21M | 0.04% | 435 |
|
|
2014
Q3 | $2.78M | Sell |
40,400
-78,800
| -66% | -$5.42M | 0.01% | 687 |
|
|
2014
Q2 | $12.5M | Buy |
119,200
+26,600
| +29% | +$2.79M | 0.06% | 339 |
|
|
2014
Q1 | $7.68M | Sell |
92,600
-5,100
| -5% | -$423K | 0.04% | 428 |
|
|
2013
Q4 | $6.32M | Sell |
97,700
-4,600
| -4% | -$298K | 0.03% | 455 |
|
|
2013
Q3 | $6.48M | Sell |
102,300
-52,700
| -34% | -$3.34M | 0.04% | 447 |
|
|
2013
Q2 | $6.51M | Buy |
+155,000
| New | +$6.51M | 0.04% | 420 |
|